ML Research Intern, PhD - 2026 at Genesis Therapeutics

New York, New York, United States

Apply Now

Not SpecifiedCompensation

InternshipExperience Level

InternshipJob Type

UnknownVisa

Biotechnology, Pharmaceuticals, Artificial IntelligenceIndustries

Requirements

Currently enrolled in a PhD program in Computer Science, Machine Learning, or related fields
Creative researcher with a strong background in machine learning, deep learning, and/or related areas
First-principles thinker passionate about tackling open-ended scientific problems
Curious about the intersection of AI and biochemistry and excited to learn about the drug discovery process

Responsibilities

Lead a novel research project from ideation to conclusion, focused on a critical challenge in generative or predictive AI for molecular systems
Push the research frontier by engaging with the latest literature on foundation models, developing new methods in areas like diffusion or RL, and rigorously testing hypotheses at scale
Design and run experiments at scale to validate the most promising approaches and hypotheses
Present work to the team and contribute insights to the broader research agenda (strong projects may lead to publications in top-tier venues)

Skills

Deep Learning

Generative AI

Diffusion Models

LLMs

Reinforcement Learning

Multi-modal Learning

Machine Learning

Computational Chemistry

Molecular Modeling

Foundation Models

Genesis Therapeutics

AI-driven drug discovery for pharmaceuticals

About Genesis Therapeutics

Genesis Therapeutics accelerates the development of new medicines by using artificial intelligence in drug discovery. The company combines 3D spatial graph modeling and molecular simulation to identify potential drug candidates and explore new chemical spaces. Unlike its competitors, Genesis Therapeutics focuses on strategic partnerships with other biotech and pharmaceutical companies, generating revenue through upfront payments and future earnings based on drug success. The goal is to transform the drug discovery process and bring new therapies to market.

Burlingame, CaliforniaHeadquarters

2019Year Founded

$272.5MTotal Funding

SERIES_BCompany Stage

AI & Machine Learning, BiotechnologyIndustries

51-200Employees

Benefits

Competitive salary

Equity

Medical, dental, & vision insurance

401(k) program

Risks

Competition from AI-driven companies like Insilico Medicine and Exscientia is increasing.

Over-reliance on partnerships could lead to financial instability if drugs aren't successful.

Rapid AI advancements may render current models like GEMS obsolete without updates.

Differentiation

Genesis Therapeutics uses AI to accelerate drug discovery with 3D spatial graph modeling.

The GEMS platform integrates deep learning, molecular simulations, and generative AI for drug design.

Strategic partnerships with Eli Lilly and Gilead highlight Genesis' industry collaboration strength.

Upsides

Partnership with NVIDIA enhances GEMS platform for targeting undruggable diseases.

$224 million equity investment boosts research and development capabilities.

Recognition as a 'Fierce 15' company underscores AI's role in breakthrough therapeutics.

Land your dream remote job 3x faster with AI

Try Jobo Free